Shelter Pharma Ltd

Shelter Pharma Limited announced it has secured export orders totaling Rs 3,46,94,820.52, equivalent to USD 3,64,335, from Taha Drugs & Chemicals Co. Ltd., First Vet Veterinary Medicines Trading L.L.C, and Genet International. The orders, which are for nutraceutical and animal feed supplement products, are expected to be executed within mutually agreed timelines and do not involve any related party transactions. Shelter Pharma’s Managing Director, Mustaqim Nisarahmed Sabugar, confirmed that neither the company’s promoters, promoter group, nor group companies have any interest in the entities awarding the orders.

Shelter Pharma Ltd. is currently down 0.80% to Rs 34.85, after recently rising and gaining 3.87% over the last week. Shelter Pharma Limited announced it has received a significant export order from Berlin International Company for nutraceutical products, including D3 CURE 50 ML (3500 x 2.90), valued at USD 10,150, or Rs 9,72,360.86. The order, awarded by an international entity, represents a positive development for the company as it diversifies its revenue base and expands its presence in the global nutraceutical sector, and is expected to contribute to business and revenue growth upon execution. Shelter Pharma intends to leverage its research and development capabilities to meet international market requirements and further broaden its customer base. Shelter Pharma Ltd. shares saw a trading volume of 6000 today, a decrease of 95.83% from the one-week average volume. Shelter Pharma Ltd. declined by 19.46% year-over-year, underperforming the 7.09% loss registered by the NIFTY50 index.

The order comprises 2,000 boxes of Feedmin Bolus valued at $2,700, 2,500 boxes of Regulin Bolus worth $3,375, 1,200 pieces of Lactocal Gel valued at $3,360, and 1,500 boxes of Buta-B Bolus worth $2,850. The company said the order was received in the normal course of business and will be executed within mutually agreed timelines as per the purchase order schedule. Shelter Pharma clarified that neither its promoters nor the promoter group has any interest in Genet International. It also said the transaction does not qualify as a related-party transaction. Shelter Pharma manufactures pharmaceutical products, including herbal medicines for veterinary, poultry and human healthcare. The company's profit after tax (PAT) climbed 24.72% to Rs 9.03 crore in FY2026 from Rs 7.24 crore in FY2025, while net sales increased 44.35% year-on-year to Rs 73.13 crore. Powered by Capital Market - Live

Shelter Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Shelter Pharma has secured an order from Taha Drugs & Chemicals Co., Sudan for Joemega Capsule and All Vitamins tablet, total order worth $ 1,44,000.

The company has appointed a Zonal Sales Manager for its veterinary division, along with a Regional Sales Manager for Uttarakhand and Western Uttar Pradesh. It has also added multiple sales officers across Gujarat and Rajasthan to enhance its field presence. In addition, an export executive has been appointed at the head office to support international business development. According to the company, the appointments are part of its strategy to strengthen its sales hierarchy, improve operational efficiency, and expand market reach across regions. The move is also expected to support growth in export markets alongside domestic expansion. Shelter Pharma is a pharmaceutical manufacturing company, specializing in herbal remedies for both human and veterinary healthcare. The company's standalone net profit jumped 27.12% to Rs 4.50 crore on 38.36% rise in net sales to Rs 33.29 crore in the half year ended September 2025 over the half year ended September 2024.

The order, valued at $18,300, is to be executed within six months, the company said in a regulatory filing. The contract has been awarded by an international entity and is on a fixed-cost basis. Shelter Pharma added that neither the promoter nor the promoter group has any interest in the entity awarding the order. The company also clarified that the transaction does not fall under related party transactions. Shelter Pharma is engaged in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. Shelter is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. On a full year basis, the company's standalone net profit jumped 16.8% to Rs 7.24 crore on 26.6% rise in net sales to Rs 50.66 crore in FY25 over FY24. Powered by Capital Market - Live

Shelter Pharma has secured an order from Taha Drugs & Chemicals Co., Sudan for Joemega Capsule 3*10 Strips (BOX) total order worth 1,41,600 $. Powered by Capital Market - Live

The order is a fixed-cost contract and is to be executed within two months. The company said neither its promoters nor group companies have any interest in the entity awarding the contract. The transaction does not fall under related party transactions. Shelter Pharma is engaged in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. Shelter is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. On a full year basis, the company's standalone net profit jumped 16.8% to Rs 7.24 crore on 26.6% rise in net sales to Rs 50.66 crore in FY25 over FY24. Powered by Capital Market - Live

Shelter Pharma will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live